Find Research Projects

Search results

• A Phase IA, Open-Label, Multiple-Dose, Dose Escalation Study to Investigate the Safety and Pharmacokinetics of the BTK Inhibitor BGB-3111 in Subjects with Indolent B-Cell Lymphoid Malignancies

  Opat, S.

  5/12/19 → 4/12/24

  Project: Research

• A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the Bruton’s Tyrosine Kinase (BTK) Inhibitors BGB-3111 and Ibrutinib in Subjects with Waldenström’s Macroglobulinemia (WM)

  Opat, S.

  5/12/19 → 4/12/24

  Project: Research

• A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-Medicated Rejection in Kidney Transplant Recipients (IMAGINE)

  Mulley, W.

  2/12/19 → 1/12/24

  Project: Research

• Can and should we reform the Goods and Services Tax?

  James, K.

  Australian Research Council (ARC)

  2/12/19 → 1/12/24

  Project: Research

• De-tabooing depression and anxiety: Mental health communication in old age

  Burridge, K., Benczes, R., Allan, K. & Lindgren, M.

  1/12/21 → 30/11/24

  Project: Research

• Global Economic Uncertainty, Liquidity and Monetary Policy in Australia

  Bajaj, A.

  1/12/21 → 30/11/24

  Project: Research

• Post Graduate Jazz and Improvisation Scholarship

  Burke, R., Williamson, P. & Murray, J.

  Cripps Foundation

  29/11/18 → 28/11/24

  Project: Research

• An Open-Label, Multicentre, Long-term Extension Study of Tislelizumab-Containing Treatment and/or Pamiparib-Containing Treatment in Patients With Advanced Malignancies

  Frentzas, S.

  28/11/19 → 27/11/24

  Project: Research

• A Phase II Open-label Multicenter Study to Assess the Efficacy and Safety of AFM13 in Patients with Relapsed or Refractory CD30-positive Peripheral T-cell Lymphoma or Transformed Mycosis Fungoides (RE-DIRECT)

  Shortt, J.

  28/11/19 → 27/11/24

  Project: Research

• LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy with or without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

  Parakh, S. & Alamgeer, M.

  27/11/19 → 26/11/24

  Project: Research

• Randomized, Non-comparative Neoadjuvant Phase II Study in patients with ER+/HER2- Breast Cancer >= 2cm with Safety Run-in, Assessing Nivolumab + Abemaciclib or Palbociclib + Anastrozole

  White, M.

  27/11/19 → 26/11/24

  Project: Research

• A Multicenter, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects with Active Psoriatic Arthritis

  Roberts, L.

  21/11/19 → 20/11/24

  Project: Research

• A randomized, multicenter, parallel-group, Phase III study to compare the efficacy of arfolitixorin versus leucovorin in combination with 5-fluorouracil, oxaliplatin, and bevacizumab in patients with advanced colorectal cancer

  Frentzas, S.

  20/11/19 → 19/11/24

  Project: Research

• Exploiting Context in Multilingual Understanding and Generation

  Haffari, R.

  Australian Research Council (ARC)

  20/11/20 → 19/11/24

  Project: Research

• A Reception History of Early Modern Landscape Design

  Morgan, L.

  Australian Research Council (ARC)

  20/11/20 → 19/11/24

  Project: Research

• Phase II Study of Blinatumomab as Induction Therapy in Adolescent and Young Adult Acute Lymphoblastic Leukaemia

  Fedele, P.

  19/11/19 → 18/11/24

  Project: Research

• A Phase 1, Multicenter, Open-label, Multiple Dose escalation Study of ARX788, Intravenously Administered as a Single Agent in Subjects with Advanced Cancers with HER2 Expression

  Markman, B. & Frentzas, S.

  16/11/18 → 15/11/24

  Project: Research

• A Randomized, Multicenter, Double-blind, Placebo-controlled Phase 3 Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Patients With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer

  Webber, K.

  15/11/19 → 14/11/24

  Project: Research

• RSV MAT-004 - A Phase II observer-blind study to assess safety, reactogenicity and immunogenicity of GSK Biologicals’ investigational RSV Maternal unadjuvanted vaccine (GSK3888550A), in healthy pregnant women and infants born to vaccinated mothers

  Buttery, J.

  15/11/19 → 14/11/24

  Project: Research

• A Phase 1a/1b, Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK112 in Subjects with Advanced Solid Tumors

  Parakh, S.

  15/11/19 → 14/11/24

  Project: Research

• A Phase 3, Multicentre, Open Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

  Moore, G.

  7/11/19 → 6/11/24

  Project: Research

• A Phase 3, Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

  Moore, G.

  7/11/19 → 6/11/24

  Project: Research

• A Phase 3, Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

  Moore, G.

  7/11/19 → 6/11/24

  Project: Research

• A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-641)

  Pook, D.

  6/11/19 → 5/11/24

  Project: Research

• A Phase 1/Phase 2 Clinical Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants with Hematologic Malignancies

  Gregory, G.

  6/11/19 → 5/11/24

  Project: Research

• Interacting with change: inter-specific competition and climate change

  Kellermann, V.

  Australian Research Council (ARC), Monash University – Internal School Contribution

  2/11/20 → 2/11/24

  Project: Research

• The World Mosquito Program: Protecting 100 million people by 2023

  O'Neill, S.

  Macquarie Group Foundation

  1/11/19 → 1/11/24

  Project: Research

• A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: the PROOF Trial

  Harris, M.

  1/11/19 → 31/10/24

  Project: Research

• A Phase 3b, Open-Label, Single-Arm, Rollover Study to Evaluate Long-Term Safety in Subjects who have participated in other Luspatercept (ACE-536) Clinical Trials

  Kaplan, Z.

  1/11/19 → 31/10/24

  Project: Research

• Centre for Research Excellence - Women’s Health in Reproductive life

  Teede, H., Norman, R. J., Mishra, G. D., Boyle, J., Hart, R. J., Mol, B., Moran, L., Hickey, M., Laven, J. S. E. & Rodgers, R. J.

  1/11/19 → 31/10/24

  Project: Research

• A Study to Evaluate the Feasibility and Safety of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation (Millipede Feasibility Study)

  Gooley, R.

  1/11/19 → 31/10/24

  Project: Research

• Low Back Pain Centre for Research Excellence

  Maher, C., Buchbinder, R., Hancock, M. J., O'Sullivan, P. B., McAuley, J., Blyth, F. M., Jorm, L., Collie, A., McCaffery, K. & Hayes, A. J.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/11/19 → 31/10/24

  Project: Research

• Better health through better trials: A national network to develop and implement innovative clinical trials methodology

  Wolfe, R., Lee, K. J., Forbes, A., Webb, S. A. R., Marschner, I. C., Makrides, M., Snelling, T. L., Davidson, A., Heritier, S., Yelland, L. & Hawley, C.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/11/19 → 31/10/24

  Project: Research

• Centre of Research Excellence in Health in Preconception and Pregnancy: Prevention of maternal obesity

  Skouteris, H., Teede, H., Boyle, J., Moran, L., Thangaratinam, S., Hills, A. P., Venn, A., Jack, B., Norman, R. J. & Ademi Delaney, Z.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/11/19 → 31/10/24

  Project: Research

• A Phase 1b/2 Study of KZR-616 in Patients Rheumatic Disease with Active Inflammatory Arthritis and in Patients with Lupus Nephritis

  Ghali, J. & Hoi, A.

  1/11/19 → 31/10/24

  Project: Research

• An International, Phase 3, Open-label, Randomized Study of BGB-3111 Compared with Bendamustine plus Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  Opat, S.

  1/11/19 → 31/10/24

  Project: Research

• Centre of Research Excellence in Paediatric Emergency Medicine

  Babl, F. E., Oakley, E., Dalziel, S. R., Borland, M., Middleton, S., Donath, S., Craig, S., Tavender, E. J., Phillips, N. A. & Dalziel, K.

  1/11/19 → 31/10/24

  Project: Research

• Centre for Research Excellence in Digestive Health

  Talley, N., Holtmann, G. J., Walker, M. M., Jones, M., Morrison, M., Keely, S., Gibson, P., Chan, S., Tack, J. & Coombes, J. S.

  1/11/19 → 31/10/24

  Project: Research

• A Phase 3 Study of Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  Briggs, P.

  1/11/19 → 31/10/24

  Project: Research

• Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Locally Advanced Rectal Cancer: A Multicentre Randomised Study. (DYNAMIC-RECTAL).

  Gill, S. & Cross, N.

  30/09/18 → 30/10/24

  Project: Research

• A 24-week multi-center, double-blind, placebo controlled dose-range finding study to investigate the efficacy and safety of oral QBW251 in COPD patients on triple inhaled therapy (LABA/LAMA/ICS)

  Bardin, P.

  29/10/19 → 28/10/24

  Project: Research

• A Phase 2 Study of Olaparib in combination with pembrolizumab in participants with homologous recombination repair mutation (HRRm) and/or homologous recombination deficiency (HRD)-positive advanced cancer

  Frentzas, S.

  28/10/19 → 27/10/24

  Project: Research

• A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  Nicholls, S.

  24/10/19 → 23/10/24

  Project: Research

• QUASAR: A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis

  Moore, G.

  24/10/19 → 23/10/24

  Project: Research

• A Phase III Open-Label, Multicentre Trial of Maintenance Therapy with Avelumab (MSB0010718C) Versus Continuation of First-Line Chemotherapy in Subjects with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of Stomach, or of the Gastro-Esophageal Junction

  Strickland, A.

  18/10/19 → 17/10/24

  Project: Research

• An adaptive Phase 2 randomized double-blind, placebo controlled multi-center study to evaluate the safety and efficacy of multiple LOU064 doses in patients with moderate to severe Sjögren’s Syndrome (LOUiSSe)

  Hoi, A.

  18/10/19 → 17/10/24

  Project: Research

• A multicentre, prospective, open label study to assess the safety and performance of the Genio™ bilateral hypoglossal nerve stimulation system for the treatment of Obstructive Sleep Apnoea in adult patients with and without complete concentric collapse of the soft palate

  Mansfield, D.

  18/10/19 → 17/10/24

  Project: Research

• A Single and Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB-729 Administered by Subcutaneous Injection to Healthy Subjects and Subjects with Chronic Hepatitis B Infection

  Sievert, W.

  16/10/19 → 15/10/24

  Project: Research

• Synthesis, Synergy and Sustainability: Development of active-metal reagents

  Blair, V.

  Australian Research Council (ARC)

  12/10/20 → 11/10/24

  Project: Research

• A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects with Chronic Lymphocytic Leukaemia

  Opat, S.

  10/10/19 → 9/10/24

  Project: Research